EUR 23.6
(1.72%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 8.33 Million EUR | 112664.99% |
2022 | 7390.00 EUR | -66.19% |
2021 | 21.85 Thousand EUR | -99.27% |
2020 | 3 Million EUR | 0.0% |
2019 | 3 Million EUR | -78.57% |
2018 | 14 Million EUR | 0.0% |
2017 | 14 Million EUR | 0.0% |
2016 | 14 Million EUR | 40.15% |
2015 | 9.98 Million EUR | -57.23% |
2014 | 23.35 Million EUR | 36.91% |
2013 | 17.05 Million EUR | 34.22% |
2012 | 12.7 Million EUR | 111.82% |
2011 | 6 Million EUR | 53.1% |
2010 | 3.91 Million EUR | 0.0% |
2009 | - EUR | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 8.33 Million EUR | 0.0% |
2023 Q4 | 8.33 Million EUR | 0.0% |
2023 Q2 | 9.92 Million EUR | 0.0% |
2023 FY | 8.33 Million EUR | 112664.99% |
2022 Q2 | 14.67 Thousand EUR | 0.0% |
2022 Q4 | 7390.00 EUR | 0.0% |
2022 FY | 7390.00 EUR | -66.19% |
2021 Q4 | 21.85 Thousand EUR | 0.0% |
2021 Q2 | 3 Million EUR | 0.0% |
2021 FY | 21.85 Thousand EUR | -99.27% |
2020 Q2 | 3 Million EUR | 0.0% |
2020 FY | 3 Million EUR | 0.0% |
2020 Q4 | 3 Million EUR | 0.0% |
2019 FY | 3 Million EUR | -78.57% |
2019 Q4 | 3 Million EUR | 0.0% |
2019 Q2 | 14 Million EUR | 0.0% |
2018 Q4 | 14 Million EUR | 0.0% |
2018 FY | 14 Million EUR | 0.0% |
2018 Q2 | 14 Million EUR | 0.0% |
2017 Q4 | 14 Million EUR | 0.0% |
2017 Q2 | 14 Million EUR | 0.0% |
2017 FY | 14 Million EUR | 0.0% |
2016 FY | 14 Million EUR | 40.15% |
2016 Q2 | 7.01 Million EUR | 0.0% |
2016 Q4 | 14 Million EUR | 0.0% |
2015 Q4 | 9.98 Million EUR | 0.0% |
2015 FY | 9.98 Million EUR | -57.23% |
2015 Q2 | 35.83 Million EUR | 0.0% |
2014 Q4 | 23.35 Million EUR | 0.0% |
2014 FY | 23.35 Million EUR | 36.91% |
2014 Q2 | 21.36 Million EUR | 0.0% |
2013 Q4 | 17.05 Million EUR | 0.0% |
2013 FY | 17.05 Million EUR | 34.22% |
2013 Q2 | 22.2 Million EUR | 0.0% |
2012 Q3 | 12.7 Million EUR | 45.42% |
2012 Q1 | 8.73 Million EUR | 45.66% |
2012 FY | 12.7 Million EUR | 111.82% |
2012 Q2 | 8.73 Million EUR | 0.0% |
2012 Q4 | 12.7 Million EUR | 0.0% |
2011 FY | 6 Million EUR | 53.1% |
2011 Q4 | 6 Million EUR | 0.0% |
2011 Q2 | 3.5 Million EUR | 0.0% |
2010 Q4 | 3.91 Million EUR | 0.0% |
2010 FY | 3.91 Million EUR | 0.0% |
2009 FY | - EUR | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Apontis Pharma AG | 6 Million EUR | -38.889% |
Dermapharm Holding SE | 950.7 Million EUR | 99.123% |
Evotec SE | 477.11 Million EUR | 98.253% |
MERCK Kommanditgesellschaft auf Aktien | 8.84 Billion EUR | 99.906% |
PharmaSGP Holding SE | 65.37 Million EUR | 87.252% |
SynBiotic SE | 2.89 Million EUR | -188.007% |